Elixinol Wellness Limited
ELLXFOTCHealthcare● Active
$0.01
+$0.00(+21.95%)
Market Cap$1087000
P/E Ratio—
52W High$0.0289
52W Low$0.0024
Elixinol Wellness Limited (ELLXF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ELLXF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $15.49M | $14.96M | $8.27M | $7.05M | $9.34M |
| Cost of Revenue | $14.74M | $9.31M | $4.85M | $10.32M | $15.59M |
| Gross Profit | $0.75M | $5.64M | $3.42M | ($3.27M) | ($6.25M) |
| Gross Margin %(computed) | 4.85% | 37.72% | 41.36% | -46.29% | -66.98% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $5.48M | $6.17M | $4.44M | $12.95M |
| Total Operating Expenses | $5.73M | $10.75M | $9.88M | $6.74M | $9.35M |
| Operating Income | ($4.97M) | ($5.11M) | ($6.46M) | ($10.00M) | ($15.61M) |
| Operating Margin %(computed) | -32.10% | -34.14% | -78.15% | -141.77% | -167.16% |
| Interest Income | $0.01M | $0.03M | $0.21M | $0.02M | $0.05M |
| Interest Expense | $0.49M | $0.18M | $0.10M | $0.07M | $0.09M |
| Income Before Tax | ($6.03M) | ($5.31M) | ($7.50M) | ($10.57M) | ($17.09M) |
| Income Tax Expense | ($0.53M) | ($3.59M) | $0.00M | $0.00M | ($0.07M) |
| Net Income | ($5.50M) | ($1.72M) | ($7.51M) | ($10.57M) | ($17.02M) |
| Net Margin %(computed) | -35.48% | -11.51% | -90.78% | -149.84% | -182.32% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.01 | $-0.10 | $-0.03 | $-0.04 |
| Wtd Avg Shares | 256.21M | 154.55M | 75.88M | 406.38M | 404.77M |
| EBITDA | ($4.11M) | ($4.09M) | ($6.81M) | ($9.28M) | ($15.12M) |
| EBITDA Margin %(computed) | -26.50% | -27.36% | -82.31% | -131.55% | -161.94% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · AUD · M
Explore more Elixinol Wellness Limited data
About Elixinol Wellness Limited (ELLXF) Income Statement
Elixinol Wellness Limited (ELLXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ELLXF reported revenue of $0.02B, gross profit of $0.00B (gross margin 4.85%), and net income of ($0.01B) — a net profit margin of -35.48%.
Frequently asked questions
ELLXF · 4 questionsElixinol Wellness Limited (ELLXF) reported revenue of $0.02B for 2025, up 3.6% year-over-year.
ELLXF revenueELLXF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09